CoChat

Increased cellular senescence in doxorubicin-induced murine ovarian injury: effect of senolytics

Open access

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

Ovarian injury caused by chemotherapy can lead to early menopause, infertility, and even premature senility in female cancer patients, impairing the quality of life and overall health of the cancer survivors seriously. However, there is still a lack of effective protection strategies against such injury. Cellular senescence can be induced by chemotherapeutic agents in multiple organs and may corrode the structure and function of normal tissues. We hypothesized that the widely used first-line chemotherapy drug, doxorubicin, could increase senescent cell burden in normal ovarian tissue during the therapeutic process and that elimination of senescent cells with senolytics would ameliorate doxorubicin-induced ovarian injury. Here, we demonstrated an accumulation of cellular senescence in doxorubicin-treated ovaries through detecting p16 and p21 expression levels and senescence-associated β-galactosidase (SA-β-gal) activity as well as senescence-associated secretory phenotype (SASP) factors. Short-term intervention with the classic senolytic combination dasatinib and quercetin (DQ) or fisetin significantly reduced the load of senescent cells in ovaries after doxorubicin treatment. However, neither DQ nor fisetin alleviated doxorubicin-related ovarian dysfunction. Further experiments showed that ovarian apoptosis and fibrosis following doxorubicin exposure could not be improved by senolytics. Collectively, our study shows that senolytic treatment can eliminate accumulated senescent cells, but cannot reverse the massive follicle loss and ovarian stromal fibrosis caused by doxorubicin, suggesting that cellular senescence may not be one of the key mechanisms in doxorubicin-induced ovarian injury.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11357-023-00728-2

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Ovarian senescence is increased in doxorubicin-treated mice. a Schematic diagram for animal experiment design. b–d Body weight, ovary weight, and ovary index of mice after saline or doxorubicin injection (n = 16, unpaired Student’s t-test). e The proportion of regular or irregular estrous cycles after saline or doxorubicin injection (n = 16, Chi-square test). f The serum levels of AMH, FSH, and E2 at diestrus (n = 6, unpaired Student’s t-test). g The proportion of follicles at different stages (PMF: primordial follicles, GF: growing follicles, ATF: atretic follicles). h Representative H&E staining images of murine ovaries. Yellow arrows: primordial follicles, red arrows: primary follicles, blue arrows: secondary follicles, black arrows: zona pellucida remnants. ANF: antral follicles. i Follicle counting results based on H&E staining of serial ovarian sections (n ≥ 5, unpaired Student’s t-test). j Representative images of SA-β-gal staining and IHC detection of p16 and p21 in the murine ovaries. k IHC scores of relative expression of p16 and p21 based on IOD (n = 3, unpaired Student’s t-test). IOD: integrated optical density. l, m Protein expression of p16 and p21 in ovarian tissues detected by western blot. n Relative mRNA expression of genes related to cellular senescence and SASP (n = 3, unpaired Student’s t-test). Data are presented as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001
Fig. 1 Ovarian senescence is increased in doxorubicin-treated mice. a Schematic diagram for animal experiment design. b–d Body weight, ovary weight, and ovary index of mice after saline or doxorubicin injection (n = 16, unpaired Student’s t-test). e The proportion of regular or irregular estrous cycles after saline or doxorubicin injection (n = 16, Chi-square test). f The serum levels of AMH, FSH, and E2 at diestrus (n = 6, unpaired Student’s t-test). g The proportion of follicles at different stages (PMF: primordial follicles, GF: growing follicles, ATF: atretic follicles). h Representative H&E staining images of murine ovaries. Yellow arrows: primordial follicles, red arrows: primary follicles, blue arrows: secondary follicles, black arrows: zona pellucida remnants. ANF: antral follicles. i Follicle counting results based on H&E staining of serial ovarian sections (n ≥ 5, unpaired Student’s t-test). j Representative images of SA-β-gal staining and IHC detection of p16 and p21 in the murine ovaries. k IHC scores of relative expression of p16 and p21 based on IOD (n = 3, unpaired Student’s t-test). IOD: integrated optical density. l, m Protein expression of p16 and p21 in ovarian tissues detected by western blot. n Relative mRNA expression of genes related to cellular senescence and SASP (n = 3, unpaired Student’s t-test). Data are presented as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001CC BY · PubMed Central
Fig. 2 Senolytics cannot alleviate doxorubicin-induced ovarian injury. a Brief schematic diagram for animal experiment design. b–d Body weight, ovary weight, and ovary index of mice in each group (n ≥ 16, one-way ANOVA). e The proportion of regular or irregular estrous cycles in each group (n ≥ 18, Chi-square test). f The serum levels of AMH, FSH, and E2 at diestrus (n = 6, one-way ANOVA). g Representative H&E staining images of murine ovaries from each group. Yellow arrows: primordial follicles, red arrows: primary follicles, blue arrows: secondary follicles, black arrows: zona pellucida remnants. ANF: antral follicles, ATF: atretic follicles. h Follicle counting results according to H&E staining of serial ovarian sections (n ≥ 5, one-way ANOVA). i The proportion of follicles at different stages (PMF: primordial follicles, GF: growing follicles). j The proportion of successful pregnant mice in the mating test (n = 12, Chi-square test). k Average litter size of total mated mice (n = 12, one-way ANOVA). l Average litter size of post-delivery mice (n = 3~11, one-way ANOVA). m General state of pups in different groups. Data are presented as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001
Fig. 2 Senolytics cannot alleviate doxorubicin-induced ovarian injury. a Brief schematic diagram for animal experiment design. b–d Body weight, ovary weight, and ovary index of mice in each group (n ≥ 16, one-way ANOVA). e The proportion of regular or irregular estrous cycles in each group (n ≥ 18, Chi-square test). f The serum levels of AMH, FSH, and E2 at diestrus (n = 6, one-way ANOVA). g Representative H&E staining images of murine ovaries from each group. Yellow arrows: primordial follicles, red arrows: primary follicles, blue arrows: secondary follicles, black arrows: zona pellucida remnants. ANF: antral follicles, ATF: atretic follicles. h Follicle counting results according to H&E staining of serial ovarian sections (n ≥ 5, one-way ANOVA). i The proportion of follicles at different stages (PMF: primordial follicles, GF: growing follicles). j The proportion of successful pregnant mice in the mating test (n = 12, Chi-square test). k Average litter size of total mated mice (n = 12, one-way ANOVA). l Average litter size of post-delivery mice (n = 3~11, one-way ANOVA). m General state of pups in different groups. Data are presented as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001CC BY · PubMed Central
Fig. 3 Senolytics can reduce ovarian senescence in doxorubicin-treated mice. a Representative SA-β-gal staining images of murine ovarian sections. b, c Representative images of p16 and p21 expression in murine ovaries by IHC. d, e IHC scores of relative expression of p16 and p21 based on IOD (n = 3, one-way ANOVA). f, g Protein expression of p16 and p21 in ovarian tissues shown by western blot. h Relative mRNA expression levels of genes related to cellular senescence and SASP in ovaries (n = 3, one-way ANOVA). Data are presented as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001
Fig. 3 Senolytics can reduce ovarian senescence in doxorubicin-treated mice. a Representative SA-β-gal staining images of murine ovarian sections. b, c Representative images of p16 and p21 expression in murine ovaries by IHC. d, e IHC scores of relative expression of p16 and p21 based on IOD (n = 3, one-way ANOVA). f, g Protein expression of p16 and p21 in ovarian tissues shown by western blot. h Relative mRNA expression levels of genes related to cellular senescence and SASP in ovaries (n = 3, one-way ANOVA). Data are presented as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001CC BY · PubMed Central
Fig. 4 Senolytics have no protective effect against ovarian apoptosis after doxorubicin treatment. a, c Expression of DNA damage marker γH2AX in murine ovaries detected by IHC (n = 3, one-way ANOVA). b Representative TUNEL staining images of ovarian sections. Green fluorescent dots indicate TUNEL-positive apoptotic cells. d–f Relative mRNA expression of apoptosis-related genes in ovaries (n = 3, one-way ANOVA). Data are presented as mean ± SD. *p < 0.05, **p < 0.01
Fig. 4 Senolytics have no protective effect against ovarian apoptosis after doxorubicin treatment. a, c Expression of DNA damage marker γH2AX in murine ovaries detected by IHC (n = 3, one-way ANOVA). b Representative TUNEL staining images of ovarian sections. Green fluorescent dots indicate TUNEL-positive apoptotic cells. d–f Relative mRNA expression of apoptosis-related genes in ovaries (n = 3, one-way ANOVA). Data are presented as mean ± SD. *p < 0.05, **p < 0.01CC BY · PubMed Central
Fig. 5 Senolytics cannot prevent ovarian fibrosis after doxorubicin treatment. a Immunofluorescence images of ovarian sections stained with α-SMA antibody. Red fluorescence indicates α-SMA-positive cells. b Representative images of Sirius red staining in murine ovaries. c–d The percentage of α-SMA positive cells and Sirius red positive area in ovarian sections (n = 3, one-way ANOVA). e Relative mRNA expression of fibrosis-related genes in ovaries (n = 3, one-way ANOVA). Data are presented as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001
Fig. 5 Senolytics cannot prevent ovarian fibrosis after doxorubicin treatment. a Immunofluorescence images of ovarian sections stained with α-SMA antibody. Red fluorescence indicates α-SMA-positive cells. b Representative images of Sirius red staining in murine ovaries. c–d The percentage of α-SMA positive cells and Sirius red positive area in ovarian sections (n = 3, one-way ANOVA). e Relative mRNA expression of fibrosis-related genes in ovaries (n = 3, one-way ANOVA). Data are presented as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Cited by

See all 56

Metadata

Authors
Gao, Y., Wu, T., Tang, X., Wen, J., Zhang, Y., Zhang, J., & Wang, S.
Affiliations
Tongji Hospital (CN)
Corresponding author
  • Zhang, Jinjin
  • Wang, Shixuan
Venue
GeroScience
Published
2023-01-17
Volume
45
Issue
3
Pages
1775-1790
ISSN
  • 2152-4041 (ISSN-L)
  • 2509-2723
OpenAlex
W4316927759
Cited by
56
References
53
Citations by year
2026: 16 · 2025: 17 · 2024: 19 · 2023: 4
FWCI
9.89
Type
journal article
Language
en
Open access
Licence
Locations
  • GeroScience (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Huazhong University of Science and Technology
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
  • Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
Keywords
cellular senescence, doxorubicin, senolytics, fisetin, senescence-associated secretory phenotype, p16, p21, senescence-associated β-galactosidase, ovarian apoptosis, follicle loss, premature ovarian aging, female cancer survivors
MeSH terms
Dasatinib, Senotherapeutics, Animals, Doxorubicin, Female, Fibrosis, Quality of Life, Cellular Senescence, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increased cellular senescence in doxorubicin-induced murine ovarian injury: effect of senolytics. https://app.cochat.ai/papers/10.1007/s11357-023-00728-2
The paper
Gao, Y., Wu, T., Tang, X., Wen, J., Zhang, Y., Zhang, J., & Wang, S. (2023). Increased cellular senescence in doxorubicin-induced murine ovarian injury: effect of senolytics. GeroScience. https://doi.org/10.1007/s11357-023-00728-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.